Sign In
Buy AMRS
$0.0500
+0 (+0%)
At Close: Nov 27, 2023
Better Buy: Gingko Bioworks vs. Amyris
10:11am, Sunday, 22'nd May 2022 The Motley Fool
Which of these fallen stocks has the best chance of recovery?
Better Buy: Gingko Bioworks vs. Amyris
06:11am, Sunday, 22'nd May 2022
Which of these fallen stocks has the best chance of recovery?
Amyris: A Question Of Agency Costs
08:27am, Monday, 16'th May 2022
Amyris' cash burn is currently high and their balance sheet weak, placing them in a vulnerable position as sentiment deteriorates. The business continues to expand rapidly, but margin improvements hav
Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1
11:48am, Thursday, 12'th May 2022 Zacks Investment Research
Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.
Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1
09:02am, Thursday, 12'th May 2022
Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.
Amyris: Elevated Cash Usage Causes Investors To Head For The Exits
01:51pm, Wednesday, 11'th May 2022
Discussing sell-off in the shares after the company's Q1 report revealed a much higher cash usage than anticipated by market participants. Even when assuming cash usage to trend down for the remainder
Amyris (AMRS) Q1 2022 Earnings Call Transcript
12:30am, Wednesday, 11'th May 2022 The Motley Fool
AMRS earnings call for the period ending March 31, 2022.
Amyris, Inc. (AMRS) CEO John Melo on Q1 2022 Results - Earnings Call Transcript
03:01pm, Tuesday, 10'th May 2022
Amyris, Inc. (NASDAQ:AMRS ) Q1 2022 Results Conference Call May 10, 2022 9:00 AM ET Company Participants John Melo - President and Chief Executive Officer Han Kieftenbeld - Chief Financial Officer Con
Amyris, Inc. (AMRS) Reports Q1 Loss, Misses Revenue Estimates
01:25pm, Tuesday, 10'th May 2022 Zacks Investment Research
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -54.17% and 11.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amyris, Inc. (AMRS) Reports Q1 Loss, Misses Revenue Estimates
10:32am, Tuesday, 10'th May 2022
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -54.17% and 11.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for May 2nd
11:47am, Monday, 02'nd May 2022 Zacks Investment Research
ALEC, AMRS, and BLFS have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2022
New Strong Sell Stocks for May 2nd
09:02am, Monday, 02'nd May 2022
ALEC, AMRS, and BLFS have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2022
Amyris, Inc. (AMRS) Gains But Lags Market: What You Should Know
10:15pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Amyris, Inc. (AMRS) closed the most recent trading day at $3.56, moving +1.42% from the previous trading session.
Amryis Update: Building Value One Brick At A Time
05:04pm, Thursday, 28'th Apr 2022
2022 is the year of the “Brick” for Amyris as it completes construction of the World's Largest Fermentation Plant, Consumer Production Facilities, and entry into global “Brick-and-Mortar” Reta
Amyris, Inc. (AMRS) Gains As Market Dips: What You Should Know
10:15pm, Friday, 08'th Apr 2022 Zacks Investment Research
Amyris, Inc. (AMRS) closed the most recent trading day at $4.48, moving +0.45% from the previous trading session.
